Trial Profile
Efficacy of everolimus versus thalidomide in patients achieving remission after first-line therapy for high-risk diffuse large B-cell lymphoma: A phase II randomised open-label study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jun 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Thalidomide
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 28 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology